Complex purinergic signaling pathways in CAVD involve the deregulation of many ecto-enzyme activities and adenosine receptor expression, which originate from various types of cells that build and pathologically infiltrate aortic valves. This evidence concerns the gene TRIM33 and congenital bilateral aplasia of vas deferens from CFTR mutation.